Cyclodextrine Based Nanogels and Phase Solubility Studies of Flurbiprofen as a Chemopreventive Agent †
Department of Pharmaceutical Technology, Faculty of Pharmacy, Gazi University, Etiler 06330, Ankara, Turkey
*
Author to whom correspondence should be addressed.
†
Presented at the 2nd International Conference on Natural Products for Cancer Prevention and Therapy, Kayseri, Turkey, 8–11 November 2017.
Proceedings 2017, 1(10), 1005; https://doi.org/10.3390/proceedings1101005
Published: 15 November 2017
(This article belongs to the Proceedings of Proceedings of the 2nd International Conference on Natural Products for Cancer Prevention and Therapy)
Abstract
:Flurbiprofen (FB) is one of the nonsteroidal anti-inflammatory drugs (NSAIDs) which has low water solubility (1). In recent studies it is shown that NSAIDs tend to demonstrate chemopreventive activity and chemoprotective agents frequently show low water solubility (2). In this study FB was selected as a model drug. Cyclodextrins (CDs) which are natural products and have special structure (hydrophobic inner phase and hydrophilic outer phase), have been widely used to enhance solubility and stability of drug substances (3). The objective of this study was to prepare CD based nanogels for increasing solubility and stability of FB. Nanogels were prepared with two different ratio (0.02 and 20%) and type of CD (βCD and HPβCD) using emulsification-solvent evaporation technique. Particle size (PS), polydispersity index (PDI), zeta potential (ZP) were investigated and phase solubility studies were performed to optimize CD based nanogels. According to results of phase solubility studies; it was achieved to enhance water solubility of FB with HPβCD 56.7 fold. PS, PDI and ZP were found as 154.5 ± 3.1 nm, 0.25 ± 0.01, −60 ± 2 mV for 0.02% HPβCD and 270.7 ± 58.2nm, 0.52 ± 0.06, −28.9 ± 2.3 mV for 20% HPβCD respectively. It can be concluded that HPβCD based nanogels can be promising carriers for FB as a chemopreventive agent.
Conflicts of Interest
The authors declare no conflict of interest.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Oktay, A.N.; Tamer, S.İ.; Çelebi, N. Cyclodextrine Based Nanogels and Phase Solubility Studies of Flurbiprofen as a Chemopreventive Agent. Proceedings 2017, 1, 1005. https://doi.org/10.3390/proceedings1101005
AMA Style
Oktay AN, Tamer Sİ, Çelebi N. Cyclodextrine Based Nanogels and Phase Solubility Studies of Flurbiprofen as a Chemopreventive Agent. Proceedings. 2017; 1(10):1005. https://doi.org/10.3390/proceedings1101005
Chicago/Turabian StyleOktay, Ayşe Nur, Sibel İlbasmiş Tamer, and Nevin Çelebi. 2017. "Cyclodextrine Based Nanogels and Phase Solubility Studies of Flurbiprofen as a Chemopreventive Agent" Proceedings 1, no. 10: 1005. https://doi.org/10.3390/proceedings1101005
